MY199600A - Use of emblica extract in preparing pharmaceutical composition for protecting mitochondria in retina - Google Patents
Use of emblica extract in preparing pharmaceutical composition for protecting mitochondria in retinaInfo
- Publication number
- MY199600A MY199600A MYPI2017001382A MYPI2017001382A MY199600A MY 199600 A MY199600 A MY 199600A MY PI2017001382 A MYPI2017001382 A MY PI2017001382A MY PI2017001382 A MYPI2017001382 A MY PI2017001382A MY 199600 A MY199600 A MY 199600A
- Authority
- MY
- Malaysia
- Prior art keywords
- pharmaceutical composition
- retina
- mitochondria
- emblica extract
- preparing pharmaceutical
- Prior art date
Links
- 210000003470 mitochondria Anatomy 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 210000001525 retina Anatomy 0.000 title abstract 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 abstract 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 230000002207 retinal effect Effects 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 230000010627 oxidative phosphorylation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW105131040A TWI666023B (zh) | 2016-09-26 | 2016-09-26 | 餘甘子萃取物用於製備保護視網膜中粒線體的醫藥組合物的用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY199600A true MY199600A (en) | 2023-11-08 |
Family
ID=61761567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2017001382A MY199600A (en) | 2016-09-26 | 2017-09-25 | Use of emblica extract in preparing pharmaceutical composition for protecting mitochondria in retina |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN107865899B (zh) |
| MY (1) | MY199600A (zh) |
| TW (1) | TWI666023B (zh) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235721B1 (en) * | 1999-02-17 | 2001-05-22 | Natreon Inc. | Stabilization of vitamin C |
| US6124268A (en) * | 1999-02-17 | 2000-09-26 | Natreon Inc. | Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| CN1112198C (zh) * | 2000-04-26 | 2003-06-25 | 中国科学院昆明植物研究所 | 叶下珠及同属植物醇提物的制药中的应用 |
| KR20030022500A (ko) * | 2001-09-10 | 2003-03-17 | 박명환 | 피부 미백용 건강식품 조성물 |
| WO2011001441A1 (en) * | 2009-06-29 | 2011-01-06 | Benny Antony | A composition of extract of emblica officinalis and method of preparing the same |
| US20050130878A1 (en) * | 2003-11-26 | 2005-06-16 | Alcon, Inc. | Prevention of photic injury by administering a TACE inhibitor |
| JP2009190988A (ja) * | 2008-02-13 | 2009-08-27 | B & C Laboratories Inc | ｐ３８ＭＡＰキナーゼ活性化抑制剤 |
| CA2794018C (en) * | 2010-03-24 | 2016-05-10 | Medical University Of South Carolina | Compositions and methods for the treatment of degenerative diseases |
| CN103585052B (zh) * | 2013-10-30 | 2015-12-30 | 无限极（中国）有限公司 | 余甘子提取物在制备具有抗辐射和抗衰老功效的保健食品或化妆品中的应用 |
-
2016
- 2016-09-26 TW TW105131040A patent/TWI666023B/zh active
-
2017
- 2017-09-12 CN CN201710816420.0A patent/CN107865899B/zh active Active
- 2017-09-25 MY MYPI2017001382A patent/MY199600A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI666023B (zh) | 2019-07-21 |
| CN107865899B (zh) | 2021-03-05 |
| CN107865899A (zh) | 2018-04-03 |
| TW201811357A (zh) | 2018-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019001760A2 (es) | Estimuladores de sgc | |
| ECSP20029790A (es) | Compuestos moduladores de sting y métodos de elaboración y uso | |
| NI201600144A (es) | Derivados de quinoxalina utiles como moduladores del fgfr cinasa | |
| CO2017002998A2 (es) | Derivados de tetrahidronaftaleno que inhiben la proteína mcl-1 | |
| CO2018004857A2 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
| MX380122B (es) | Derivado benzofurano, su metodo de preparacion, y sus usos en medicinas. | |
| MX2018015094A (es) | Derivados de carbonucleosidos sustituidos utiles como agentes antineoplasicos. | |
| CO2017012995A2 (es) | Derivados análogos de heteroarilos/arilo actvos como reguladores nrf2 y composiciones farmacéuticas de los mismos | |
| SA521421115B1 (ar) | عقاقير أولية من كربيدوبا وليفودوبا وطرق الاستخدام | |
| CL2013002517A1 (es) | Compuestos derivados de fosforoamidato de 5-fluoro-2'-desoxiuridina; procedimiento de preparacion; composicion farmaceutica que los comprende; su uso en el tratamiento o profilaxis del cancer. | |
| CU20170160A7 (es) | Derivadosde fenil-tieno(2,3-d)pirimidina- hidroxi-ésteres, un proceso para su preparación y composiciones farmacéuticas que lo contienen | |
| MY192703A (en) | Compositions containing tucaresol or its analogs | |
| GT201500091A (es) | Métodos y composiciones para el tratamiento y control de enfermedades en las plantas | |
| UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
| MX2022001697A (es) | Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos. | |
| MX2016014099A (es) | Productos de esmalte y metodos de uso. | |
| UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
| MX2022006817A (es) | Formulaciones/composiciones que comprenden un inhibidor de btk. | |
| ECSP17064196A (es) | Heterociclilmetil-tienouracilo como agonistas del receptor de adenosina a2b | |
| CR20160558A (es) | Compuesto de 1, 3, 4 - tiadiazol y uso de los mismos para el tratamiento del cáncer | |
| CO2018001615A2 (es) | Fosforamidocloridato morfolino nucleósidos activados diastereoméricamente puros o sustancialmente diastereoméricamente puros y métodos para su preparación | |
| UY38228A (es) | Compuestos de triazolopirimidina y su uso en el tratamiento del cáncer | |
| CL2017000428A1 (es) | Derivados de imidazo[1,2-a]piridina para su uso como inhibidores para la replica del virus de la inmunodeficiencia humana | |
| BR112017002965A2 (pt) | artigo absorvente com camada de proteção multiuso | |
| DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas |